United States · 
Who invested in Unicycive Therapeutics?
Unicycive Therapeutics's investors include RA Capital Management and Vivo Capital.
United States · Funded startup
Who invested in Unicycive Therapeutics
Funding summaryUpdated 26 Oct 2026
$50Mraised across 1 round since 2024, from 1 source
- Latest round
- Round, $50MMar 2024
- Investors
- 2
The rounds
- Mar 2024
Founders and team
From the SEC filings it signed: 2 on the team.
- Shalabh GuptaChief Executive Officer, President and Chairman of the Board of Directorsi
- John TownsendChief Financial Officeri
On the board, as filediGaurav AggarwalJohn RyanSandeep LaumasSara Kenkare-Mitra
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Unicycive Therapeutics
How much has Unicycive Therapeutics raised?
Unicycive Therapeutics has raised $50M across 1 round since 2024.
When did Unicycive Therapeutics last raise?
Unicycive Therapeutics's most recent round was an Undisclosed round of $50M in Mar 2024.
What was Unicycive Therapeutics's biggest round?
Its most recent round, $50M in Mar 2024, is also its largest on record.
Who backed Unicycive Therapeutics first?
Unicycive Therapeutics's first round on record, in Mar 2024, was backed by RA Capital Management and Vivo Capital.
What stage is Unicycive Therapeutics at?
Unicycive Therapeutics's latest named round is an Undisclosed round, in Mar 2024.
Where is Unicycive Therapeutics based?
Unicycive Therapeutics is based in the United States.
Companies like Unicycive Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.